Moderna sues Pfizer & BioNTech over patent infringement of  Covid-19 vaccine.

 SOURCE: Moderna, Inc.

Moderna said it is suing Pfizer and its partner BioNTech for patent infringement in the development of the first Covid-19 vaccine.

They alleging that mRNA technology it developed before the pandemic was copied.

In a statement, Moderna said Pfizer/BioNTech copied two types of its intellectual property.

One involved an mRNA structure that Moderna says its scientists began developing in 2010 and were the first to validate in human trials in 2015.

The second alleged infringement involves the coding of the spike protein on the outside of the virus itself.

This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax®.

Pfizer and BioNTech copied this technology, without Moderna's permission, to make Comirnaty®.

We believe that Pfizer and BioNTech unlawfully copied Moderna's inventions, and they have continued to use them without permission," said Moderna Chief Legal Officer

Moderna and Pfizer’s two-shot vaccines both use mRNA technology to help patients fight the coronavirus.

News source:
Moderna Inc